Art

J-GLOBAL ID：201302298130970633   Reference number：13A0418506

Randomized, Single-Blind, Parallel Study of the Effectiveness and Safety of Solifenacin versus Propiverine in the Treatment of Overactive Bladder

過活動膀胱治療におけるソリフェナシンの有効性と安全性をプロピベリンと比較した無作為化,単盲検,パラレル研究

Author (4)： FUKUDA Takehiko (Dokkyo Medical Univ., Tochigi, JPN) ,  YAMANISHI Tomonori (Dokkyo Medical Univ., Tochigi, JPN) ,  UCHIYAMA Tomoyuki (Dokkyo Medical Univ., Tochigi, JPN) ,  KAMAI Takao (Dokkyo Medical Univ., Tochigi, JPN)
Material： LUTS  (Lower Urinary Tract Symptoms)
Volume： 5  Issue： 1  Page： 11-16  Publication year： Jan. 2013 
JST Material Number： W2283A  ISSN： 1757-5664  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *bladder disease ,...
Semi thesaurus term： quality of life ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0418506&from=J-GLOBAL&jstjournalNo=W2283A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V)

Substance index (2)： Solifenacin ,  Propiverine

Reference (23)：

• Yamaguchi O, Honda K, Nomiya M et al. Defining overactive bladder as hypersensitivity. Neurourol Urodyn 2007; 16: 904-7.
• Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee. An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005; 96: 1314-8.
• Homma Y, Yoshida M, Seki N et al. Symptom assessment tool for overactive bladder syndrome-overactive bladder symptom score. Urology 2006; 68: 318-23.
• Homma Y, Kakizaki H, Yamaguchi O et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology 2011; 77: 60-4.
• Klovning A, Avery K, Sandvik H, Hunskaar S. Comparison of two questionnaires for assessing the severity of urinary incontinence: the ICIQ-UI SF versus the incontinence severity index. Neurourol Urodyn 2009; 28: 411-5.

Terms in the title (9)： 過活動膀胱 ,  治療 ,  ソリフェナシン ,  有効性 ,  安全性 ,  プロピベリン ,  盲 ,  パラレル ,  研究